Description
VGQ-25 – Iguratimod 25 mg Tablets
VGQ-25 contains Iguratimod, a disease-modifying antirheumatic drug (DMARD) used to manage rheumatoid arthritis in certain countries, according to approved prescribing information. Rheumatoid arthritis is a chronic inflammatory condition that can cause joint pain, swelling, stiffness, and reduced mobility. Iguratimod helps control inflammatory processes associated with this condition and may support long-term disease management under specialist supervision.
Key Benefits of VGQ-25
- Helps manage rheumatoid arthritis when a specialist prescribes it appropriately.
- Helps control inflammation associated with rheumatoid arthritis.
- May improve joint symptoms and physical function in suitable patients.
- Supports long-term rheumatoid arthritis management as part of an appropriate treatment plan.
- Helps patients follow a structured treatment approach under medical supervision.
Uses of VGQ-25
Healthcare professionals may prescribe Iguratimod for rheumatoid arthritis where local regulations approve its use. The medicine targets a specific inflammatory condition and does not serve as a general-purpose painkiller. Patients who experience joint pain, swelling, or stiffness should consult a healthcare professional for an accurate diagnosis and suitable treatment.
Product Specifications
- Brand Name: VGQ-25
- Active Ingredient: Iguratimod
- Strength: 25 mg
- Dosage Form: Check the official product packaging
- Company: Vin Medicament
Dosage and Administration
Take VGQ-25 only when a qualified healthcare professional prescribes it. Follow your doctor’s recommended dose and treatment schedule. Never change the dose, stop treatment, or combine this medicine with other medicines without consulting your doctor.
Precautions and Safety Information
Iguratimod can cause side effects, so patients need appropriate medical supervision. Tell your doctor about liver or kidney problems, blood disorders, pregnancy, plans for pregnancy, and any medicines you currently take. Your doctor may recommend regular blood tests and other checks to monitor your response and identify potential side effects. Contact your healthcare professional if you notice unusual symptoms during treatment.
Never share your medicine with another person. Always follow the approved prescribing information and your doctor’s advice.
VGQ-25 by Vin Medicament
Vin Medicament provides pharmaceutical product information for healthcare professionals, distributors, and business partners. Contact the company to confirm product availability, packaging details, and business enquiry options for VGQ-25.
Medical Disclaimer: Use this medicine only under qualified medical supervision and according to approved prescribing information. Verify the composition, strength, dosage form, and other product details against the official packaging before use.
